Trial Profile
Clinical study of ficlatuzumab in head and neck cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2014
Price :
$35
*
At a glance
- Drugs Ficlatuzumab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 16 Apr 2014 New trial record